- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Apr 29, 2026 | 59.58M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 61.28M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 61.46M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 61.34M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 61.26M sh |
| Stock Repurchased | Q2 2026 · Mar 31, 2026 | $355.3M |
| Stock Repurchased | Q2 2026 · Mar 31, 2025 | $79.49M |
| Capex | Q2 2026 · Mar 31, 2026 | $96.72M |
| Capex | Q2 2026 · Mar 31, 2025 | $51.99M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $205.26M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $112.34M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $453.37M |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $456.97M |
| Short Term Debt | Q2 2026 · Mar 31, 2026 | $623M |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $122.3M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $501.17M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $327.43M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $2.53B |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $2.59B |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $2.57B |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $2.34B |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $2.21B |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $2.18B |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $1.31B |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $907.39M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $2.44B |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $2.06B |
| Current Assets | Q2 2026 · Mar 31, 2026 | $2.27B |
| Current Assets | Q2 2026 · Sep 30, 2025 | $1.88B |
| Total Assets | Q2 2026 · Mar 31, 2026 | $4.97B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $4.63B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $2.19 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $4.36 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $1.78 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $3.20 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $2.25 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $4.48 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $1.83 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $3.30 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $102.29M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $197.27M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $83.84M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $153.54M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $46.12M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $83.88M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $37.23M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $67.44M |
| Net Income | Q2 2026 · Mar 31, 2026 | $134.01M |
| Net Income | Q2 2026 · Mar 31, 2026 | $267.73M |
| Net Income | Q2 2026 · Mar 31, 2025 | $108.95M |
| Net Income | Q2 2026 · Mar 31, 2025 | $196.04M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $774.66M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $1.48B |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $643.53M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $1.23B |
| Revenue | Q2 2026 · Mar 31, 2026 | $1.09B |
| Revenue | Q2 2026 · Mar 31, 2026 | $2.09B |
| Revenue | Q2 2026 · Mar 31, 2025 | $883.63M |
| Revenue | Q2 2026 · Mar 31, 2025 | $1.66B |